LOS ANGELES, July 09, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, ...

New ‘gentler’ treatment for prostate cancer gets green light but not all men will have access to it - It comes as concerns ...

NEW HAVEN, Conn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Halda Therapeutics, a clinical-stage biotechnology company developing a novel class of therapies called RIPTAC™ Therapeutics, today announced that ...

Darolutamide, also known as Nubeqa and made by Bayer, is recommended in final draft guidance to treat adults with metastatic hormone-sensitive prostate cancer in combination with androgen deprivation ...

Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

Survivorship in metastatic prostate cancer is seen as chronic management, focusing on quality of life through physical and emotional management. Carotuximab combined with Erleada shows a favorable ...

In preclinical prostate cancer models, HLD-0915 treatment resulted in tumor shrinkage and declines in prostate-specific antigen. The Food and Drug Administration (FDA) has granted Fast Track ...

Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...

Biden’s personal office revealed in May that he had been diagnosed with an “aggressive form” of prostate cancer that had ...

“As part of a treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy and hormone ...

Prostate cancer treatment options include radical prostatectomy, radiation therapy, and minimally invasive techniques like cryoablation, HIFU, and TULSA. Minimally invasive therapies generally have ...

NHS England will pilot AI-assisted, same-day prostate cancer diagnostics at Leeds, aiming to cut waits by up to a month and ...